Increased rate of glucose intolerance in endometrial cancer--a community-based study.
Glycosylated hemoglobin was compared in 22 unselected endometrial carcinoma cases 1-10 years (mean +/- SD = 3.3 +/- 2.8) after diagnosis and in 939 controls, a representative population sample in the same age range tested for oral glucose tolerance. Relative weight was similar in patients and controls. Glycosylated hemoglobin was significantly increased (p less than 0.01) in the cases. The distribution of glycosylated hemoglobin indicated that most if not all of the cases had at least impaired glucose tolerance. These results support a true association of glucose intolerance and endometrial carcinoma.
D001786:Blood Glucose / Q000378:metabolism*; D048909:Diabetes Complications; D005260:Female; D006442:Glycated Hemoglobin / Q000032:analysis; D006801:Humans; D014594:Uterine Neoplasms / Q000097:blood* / Q000150:complications
D001786:Blood Glucose; D006442:Glycated Hemoglobin